Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension

• 作者Prof Roberto Fogari, Stefano Taddei, Merete Holm-Bentzen, Jacek Baszak, Lorenzo Melani, Kai Schumacher
• 卷第30卷
• 期第9期
• 文件大小189.19KB
• 发表时间2010-09
• DOI10.2165/11536710-000000000-00000
• 页码581-597